CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 8.67
  • -0.05-0.57%
Trading May 21 09:43 CST
3.52BMarket Cap-289000P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
5.87%70.8M
-9.38%496.12M
-4.98%352.3M
0.21%233.2M
24.91%66.87M
12.38%547.48M
30.20%370.78M
37.60%232.71M
-15.61%53.54M
52.18%487.15M
Operating revenue
5.87%70.8M
-9.38%496.12M
-4.98%352.3M
0.21%233.2M
24.91%66.87M
12.38%547.48M
30.20%370.78M
37.60%232.71M
-15.61%53.54M
52.18%487.15M
Total operating cost
71.43%109.13M
-5.24%490.85M
4.16%328.85M
5.47%196.44M
3.41%63.66M
34.39%517.97M
48.28%315.7M
47.24%186.25M
35.86%61.56M
35.25%385.42M
Operating cost
-25.14%5.36M
-18.09%32M
-7.78%25.07M
-7.07%16.22M
146.53%7.16M
32.05%39.06M
28.02%27.19M
41.80%17.45M
15.48%2.9M
90.16%29.58M
Operating tax surcharges
3.60%402.43K
-6.41%3.32M
-6.08%2.09M
1.31%1.67M
17.89%388.44K
10.67%3.55M
23.76%2.23M
23.15%1.65M
-44.05%329.49K
38.12%3.21M
Operating expense
-14.35%23.92M
-10.61%257.81M
-5.07%160.31M
-0.98%102.29M
1.71%27.93M
17.47%288.39M
38.38%168.87M
55.23%103.3M
25.72%27.46M
33.62%245.51M
Administration expense
231.47%29.43M
23.01%78.31M
25.85%58.16M
5.23%33.11M
-37.30%8.88M
25.26%63.66M
33.74%46.21M
35.94%31.47M
57.73%14.16M
26.97%50.83M
Financial expense
247.42%2.28M
257.23%4.68M
181.32%2.93M
89.18%1.58M
98.56%655.18K
2,286.90%1.31M
3,793.86%1.04M
90.11%835.37K
56.76%329.97K
-109.87%-59.93K
-Interest expense (Financial expense)
98.94%2.79M
69.24%7.18M
42.10%4.54M
72.74%2.86M
127.33%1.4M
246.16%4.24M
343.03%3.2M
156.71%1.66M
107.87%617.11K
115.08%1.23M
-Interest Income (Financial expense)
34.04%-514.64K
33.60%-2.55M
24.18%-1.93M
-46.96%-1.51M
-103.61%-780.19K
-170.59%-3.85M
-162.13%-2.54M
-235.38%-1.03M
-157.79%-383.18K
-279.31%-1.42M
Research and development
155.99%47.74M
-5.95%114.73M
14.42%80.28M
31.76%41.57M
13.89%18.65M
116.45%121.99M
110.61%70.16M
38.90%31.55M
46.51%16.37M
31.90%56.36M
Credit Impairment Loss
-35.33%2.64M
87.10%-1.59M
18.85%-9.2M
-11.87%-16.79M
184.21%4.08M
-35.89%-12.3M
-65.41%-11.33M
-89.03%-15.01M
958.49%1.44M
-64.27%-9.05M
Asset Impairment Loss
236.42%6.23M
-19.96%-4.73M
1,586.33%2.26M
198.06%1.34M
-1,579.30%-4.57M
-421.91%-3.94M
-95.86%134.28K
-144.78%-1.37M
-116.76%-272.08K
153.66%1.22M
Adjustment items of total operating cost
----
----
----
----
----
----
----
----
--0.01
----
Other net revenue
Invest income
-97.11%18.66K
-71.85%1.04M
-70.93%1.02M
-81.17%644.73K
77.54%644.73K
-1.68%3.7M
512.21%3.5M
3,866.82%3.42M
320.79%363.15K
1,650.14%3.76M
Asset deal income
----
-1.70%-149.54K
-1.70%-149.54K
-46.41%-149.83K
----
-206.88%-147.05K
---147.05K
---102.34K
----
---47.92K
Other revenue
161.89%1.13M
-86.88%3.25M
494.84%2.71M
-44.20%464.79K
136.85%431.11K
525.31%24.8M
-86.75%454.86K
-63.75%833.02K
-60.82%182.02K
-28.84%3.97M
Operating profit
-845.36%-28.31M
-92.55%3.1M
-57.86%20.1M
-34.95%22.27M
160.13%3.8M
-59.03%41.62M
-34.00%47.68M
-14.67%34.23M
-130.91%-6.32M
206.63%101.58M
Add:Non operating Income
556,245.58%1.04M
389.51%12.55M
247.11%9.8M
292.68%9M
-99.57%186.79
-54.47%2.56M
-48.07%2.82M
2.52%2.29M
2,197.89%43.15K
69.27%5.63M
Less:Non operating expense
--24.44K
-93.96%32.12K
-95.66%23.07K
-96.24%20K
----
2,177.18%531.69K
4,329.58%531.69K
16,719,742.77%531.69K
--531.69K
-92.80%23.35K
Total profit
-818.61%-27.3M
-64.22%15.62M
-40.22%29.88M
-13.18%31.25M
155.82%3.8M
-59.28%43.65M
-35.66%49.98M
-15.02%35.99M
-133.30%-6.81M
196.68%107.19M
Less:Income tax cost
----
-75.54%4.18M
-60.98%3.82M
-2.97%4.8M
--1.45M
2,306.64%17.07M
--9.8M
--4.95M
----
---773.65K
Net profit
SL-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
FLtoP2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
SL-6.81M
198.82%107.96M
Net profit from continuing operation
-1,262.25%-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
134.51%2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
-133.30%-6.81M
198.82%107.96M
Less:Minority Profit
13.70%-1.3M
---6.11M
---4.23M
---2.1M
---1.51M
----
----
----
----
----
Net profit of parent company owners
-774.61%-26M
-33.94%17.56M
-24.62%30.28M
-8.04%28.55M
156.63%3.85M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
-133.30%-6.81M
198.82%107.96M
Earning per share
Basic earning per share
-774.74%-0.0641
-33.99%0.0433
-24.62%0.0747
-8.09%0.0704
156.55%0.0095
-76.60%0.0656
-51.73%0.0991
-34.02%0.0766
-130.00%-0.0168
182.95%0.2804
Diluted earning per share
-774.74%-0.0641
-33.99%0.0433
-24.62%0.0747
-8.09%0.0704
156.55%0.0095
-76.60%0.0656
-51.73%0.0991
-34.02%0.0766
-130.00%-0.0168
182.95%0.2804
Other composite income
Total composite income
-1,262.25%-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
134.51%2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
-133.30%-6.81M
198.82%107.96M
Total composite income of parent company owners
-774.61%-26M
-33.94%17.56M
-24.62%30.28M
-8.04%28.55M
156.63%3.85M
-75.38%26.58M
-48.27%40.18M
--31.04M
-133.30%-6.81M
198.82%107.96M
Total composite income of minority owners
13.70%-1.3M
---6.11M
---4.23M
---2.1M
---1.51M
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 5.87%70.8M-9.38%496.12M-4.98%352.3M0.21%233.2M24.91%66.87M12.38%547.48M30.20%370.78M37.60%232.71M-15.61%53.54M52.18%487.15M
Operating revenue 5.87%70.8M-9.38%496.12M-4.98%352.3M0.21%233.2M24.91%66.87M12.38%547.48M30.20%370.78M37.60%232.71M-15.61%53.54M52.18%487.15M
Total operating cost 71.43%109.13M-5.24%490.85M4.16%328.85M5.47%196.44M3.41%63.66M34.39%517.97M48.28%315.7M47.24%186.25M35.86%61.56M35.25%385.42M
Operating cost -25.14%5.36M-18.09%32M-7.78%25.07M-7.07%16.22M146.53%7.16M32.05%39.06M28.02%27.19M41.80%17.45M15.48%2.9M90.16%29.58M
Operating tax surcharges 3.60%402.43K-6.41%3.32M-6.08%2.09M1.31%1.67M17.89%388.44K10.67%3.55M23.76%2.23M23.15%1.65M-44.05%329.49K38.12%3.21M
Operating expense -14.35%23.92M-10.61%257.81M-5.07%160.31M-0.98%102.29M1.71%27.93M17.47%288.39M38.38%168.87M55.23%103.3M25.72%27.46M33.62%245.51M
Administration expense 231.47%29.43M23.01%78.31M25.85%58.16M5.23%33.11M-37.30%8.88M25.26%63.66M33.74%46.21M35.94%31.47M57.73%14.16M26.97%50.83M
Financial expense 247.42%2.28M257.23%4.68M181.32%2.93M89.18%1.58M98.56%655.18K2,286.90%1.31M3,793.86%1.04M90.11%835.37K56.76%329.97K-109.87%-59.93K
-Interest expense (Financial expense) 98.94%2.79M69.24%7.18M42.10%4.54M72.74%2.86M127.33%1.4M246.16%4.24M343.03%3.2M156.71%1.66M107.87%617.11K115.08%1.23M
-Interest Income (Financial expense) 34.04%-514.64K33.60%-2.55M24.18%-1.93M-46.96%-1.51M-103.61%-780.19K-170.59%-3.85M-162.13%-2.54M-235.38%-1.03M-157.79%-383.18K-279.31%-1.42M
Research and development 155.99%47.74M-5.95%114.73M14.42%80.28M31.76%41.57M13.89%18.65M116.45%121.99M110.61%70.16M38.90%31.55M46.51%16.37M31.90%56.36M
Credit Impairment Loss -35.33%2.64M87.10%-1.59M18.85%-9.2M-11.87%-16.79M184.21%4.08M-35.89%-12.3M-65.41%-11.33M-89.03%-15.01M958.49%1.44M-64.27%-9.05M
Asset Impairment Loss 236.42%6.23M-19.96%-4.73M1,586.33%2.26M198.06%1.34M-1,579.30%-4.57M-421.91%-3.94M-95.86%134.28K-144.78%-1.37M-116.76%-272.08K153.66%1.22M
Adjustment items of total operating cost ----------------------------------0.01----
Other net revenue
Invest income -97.11%18.66K-71.85%1.04M-70.93%1.02M-81.17%644.73K77.54%644.73K-1.68%3.7M512.21%3.5M3,866.82%3.42M320.79%363.15K1,650.14%3.76M
Asset deal income -----1.70%-149.54K-1.70%-149.54K-46.41%-149.83K-----206.88%-147.05K---147.05K---102.34K-------47.92K
Other revenue 161.89%1.13M-86.88%3.25M494.84%2.71M-44.20%464.79K136.85%431.11K525.31%24.8M-86.75%454.86K-63.75%833.02K-60.82%182.02K-28.84%3.97M
Operating profit -845.36%-28.31M-92.55%3.1M-57.86%20.1M-34.95%22.27M160.13%3.8M-59.03%41.62M-34.00%47.68M-14.67%34.23M-130.91%-6.32M206.63%101.58M
Add:Non operating Income 556,245.58%1.04M389.51%12.55M247.11%9.8M292.68%9M-99.57%186.79-54.47%2.56M-48.07%2.82M2.52%2.29M2,197.89%43.15K69.27%5.63M
Less:Non operating expense --24.44K-93.96%32.12K-95.66%23.07K-96.24%20K----2,177.18%531.69K4,329.58%531.69K16,719,742.77%531.69K--531.69K-92.80%23.35K
Total profit -818.61%-27.3M-64.22%15.62M-40.22%29.88M-13.18%31.25M155.82%3.8M-59.28%43.65M-35.66%49.98M-15.02%35.99M-133.30%-6.81M196.68%107.19M
Less:Income tax cost -----75.54%4.18M-60.98%3.82M-2.97%4.8M--1.45M2,306.64%17.07M--9.8M--4.95M-------773.65K
Net profit SL-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44MFLtoP2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04MSL-6.81M198.82%107.96M
Net profit from continuing operation -1,262.25%-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44M134.51%2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04M-133.30%-6.81M198.82%107.96M
Less:Minority Profit 13.70%-1.3M---6.11M---4.23M---2.1M---1.51M--------------------
Net profit of parent company owners -774.61%-26M-33.94%17.56M-24.62%30.28M-8.04%28.55M156.63%3.85M-75.38%26.58M-48.27%40.18M-26.71%31.04M-133.30%-6.81M198.82%107.96M
Earning per share
Basic earning per share -774.74%-0.0641-33.99%0.0433-24.62%0.0747-8.09%0.0704156.55%0.0095-76.60%0.0656-51.73%0.0991-34.02%0.0766-130.00%-0.0168182.95%0.2804
Diluted earning per share -774.74%-0.0641-33.99%0.0433-24.62%0.0747-8.09%0.0704156.55%0.0095-76.60%0.0656-51.73%0.0991-34.02%0.0766-130.00%-0.0168182.95%0.2804
Other composite income
Total composite income -1,262.25%-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44M134.51%2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04M-133.30%-6.81M198.82%107.96M
Total composite income of parent company owners -774.61%-26M-33.94%17.56M-24.62%30.28M-8.04%28.55M156.63%3.85M-75.38%26.58M-48.27%40.18M--31.04M-133.30%-6.81M198.82%107.96M
Total composite income of minority owners 13.70%-1.3M---6.11M---4.23M---2.1M---1.51M--------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg